Toward minimally disruptive management of symptomatic endometriosis: reducing low-value care and the burden of treatment

Abstract

Condition tags

MeSH descriptors

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (18)

• Endometriosis: Diagnosis and Management via openalex
• Management of Endometriosis: Toward Value-Based, Cost-Effective, Affordable Care via openalex
• ‘Money for nothing’. The role of robotic-assisted laparoscopy for the treatment of endometriosis via openalex
• Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study via openalex
• Pelvic Endometriosis Diagnosed in an Entire Nation Over 20 Years via openalex
• Practice Bulletin No. 114: Management of Endometriosis via openalex
• Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis via openalex
• Reducing low-value care in endometriosis between limited evidence and unresolved issues: a proposal via openalex
• Role of medical therapy in the management of deep rectovaginal endometriosis via openalex
• Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group via openalex
• The direct and indirect costs associated with endometriosis: a systematic literature review via openalex
• Treatment of pelvic pain associated with endometriosis: a committee opinion via openalex
• W125917936 via openalex
• W2735856415 via openalex
• W2613930366 via openalex
• W2132577372 via openalex
• W1998902846 via openalex
• W2163315477 via openalex

Cited by (12)

• Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023 2024
• Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not? 2023
• Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review 2021
• Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review 2021
• Endometriosis - Recent Advances, New Perspectives and Treatments 2021
• Potential Therapeutic Options and Perspectives for Alleviation of Endometrial Estrogen Dominance and Progesterone Resistance in Endometriosis 2021
• When more is not better: 10 ‘don’ts’ in endometriosis management. An ETIC* position statement 2019
• National trends in inpatient endometriosis admissions: Patients, procedures and outcomes, 2006−2015 2019
• Endometrioma: a new paradigm of diagnostics and therapeutic tactics 2019
• Bowel surgery as a fertility-enhancing procedure in patients with colorectal endometriosis: methodological, pathogenic and ethical issues 2018
• Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated? 2018
• Elagolix for endometriosis: all that glitters is not gold 2018

Source provenance

europepmc

last seen: 2026-10-01T06:15:55.914501+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:20:07.505861+00:00